• Febuxostat is used as a long-term medication to treat gout due to high uric acid levels.
  • Febuxostat is a non-purine-selective inhibitor of xanthine oxidase that inhibits the enzyme by non-competitively blocking the molybdenum pterin center. The consequence of this inhibition is the reduction of production of uric acid.
  • Febuxostat has been shown to be more effective than standard doses of Allopurinol.
  • SMB’s product offers better compliance to national guidelines due to the use of our Divule® technology which provides a flexible dosing regimen ranging from 40mg to 120mg per intake if required.
  • Our product is proposed in capsule shaped divisible tablet containing 80 mg of Febuxostat
logo blanc